Palantir alleges Marc Abramowitz betrayed the company by asking for confidential information about key projects in fields like cyber-insurance and clinical drug trials, and then filing for patents based on what he learned.
The complaint describes Abramowitz’s behavior as “brazen,” including an alleged series of visits in which he asked executives to share information about secret business plans in order to use the information for himself. It also says his lawyers invoked an Investors Rights Agreement to demand confidential documents.
http://fortune.com/2016/09/06/palantir-trade-secret-lawsuit/?xid=nl_termsheet